NIPH Clinical Trials Search

Effects of EPA/DHA on skeltal muscle in geriatric type 2 diabetic patients on admission.

Basic Information

Recruitment status	Complete: follow-up complete
Health condition(s) or Problem(s) studied	type 2 diabetes mellitus
Date of first enrollment	2019/11/01
Target sample size	20
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	Take Omega-3-acid ethyl esters everyday on admission none

Outcome(s)

Primary Outcome	grasping power and creatinine/cystatin C ratio
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	65years-old
Age maximum	Not applicable
Gender	Male and Female
Include criteria
Exclude criteria	Patients who have a history of hyperglicemic emergency, severe infecitous diseases, major surgery and severe trauma in the past 6 months Patients who will undergo a surgery within 3 months Patients who already take EPA/DHA Patients who have EPA/DHA allergy Patients suffering bleeding disease Patient's eGFR is 30 and less Patients who contact persons judge as ineligible for this study